Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Treatment of secondary hyperparathyroidism in haemodialysis patients: a randomised clinical trial comparing paricalcitol and alfacalcidol
BMC Nephrology, 09/25/09
Hansen D et al. – Hyperparathyroidism, hypercalcemia and hyperphosphatemia are associated with increased cardiovascular mortality in patients with chronic kidney disease. If there is any difference in the ability of these two vitamin D analogs to decrease the secondary hyperparathyroidism without causing hypercalcemia and hyperphosphatemia, there may also be a difference in the risk of cardiovascular mortality depending on which vitamin D analog that are used. This has potential major importance for this group of patients.
Related Articles
Time course and dose response of alpha tocopherol on oxidative stress in haemodialysis patients
BMC Nephrology, 10/27/09
Relevance Score: 88%
Pharmacokinetics and Antihypertensive Effects of Candesartan Cilexetil in Patients Undergoing Haemodialysis: An Open-Label, Single-Centre Study
Clinical Drug Investigation, 10/15/09
Relevance Score: 87%
The effect of dialysis modality on phosphate control : haemodialysis compared to haemodiafiltration. The Pan Thames Renal Audit
Nephrology Dialysis Transplantation, 11/05/09
Relevance Score: 85%
Effects of thermal therapy on uremic pruritus and biochemical parameters in patients having haemodialysis
Journal of Advanced Nursing, 11/05/09
Relevance Score: 84%
Evaluation of Oxidant-Antioxidant Balance in Patients on Maintenance Haemodialysis: A Comparative Study of Dialyzers Membranes
Nephron: Clinical Practice, 10/12/09
Relevance Score: 83%
Today in Thyroid/Parathyroid...keeping you current
Receive free subspecialty "5-minute updates" via email
Intragenic GNAS Deletion Involving Exon A/B in Pseudohypoparathyroidism Type 1A Resulting in an Apparent Loss of Exon A/B Methylation: Potential for Misdiagnosis of Pseudohypoparathyroidism Type 1B
Journal of Clinical Endocrinology and Metabolism, 12/16/09
Induction of Thyroid Gene Expression and Radioiodine Uptake in Thyroid Cancer Cells by Targeting Major Signaling Pathways
Journal of Clinical Endocrinology and Metabolism, 12/16/09
Age- and Race-Based Serum Thyrotropin Reference Limits
Journal of Clinical Endocrinology and Metabolism, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


